Question 1

How do I set a price alert for CGEM?

Accepted Answer

To set a CGEM price alert on Stock Alarm Pro, navigate to the CGEM quote page, select "Set Alert," choose your trigger type (price target, % move, RSI level, MACD, or volume breakout), and set your delivery channel. Stock Alarm Pro supports instant push notifications, SMS, and automated phone call alerts.

Question 2

Can I get phone call alerts for CGEM?

Accepted Answer

Yes. Stock Alarm Pro provides real-time automated phone call alerts for CGEM. Phone call alerts ensure you are immediately awakened or interrupted during critical volatility events, overnight earnings moves, or strict stop-loss levels when silent push notifications might be overlooked.

Question 3

What types of alerts can I set for Cullinan Therapeutics Inc?

Accepted Answer

Stock Alarm Pro supports over 125 trigger types for CGEM: price target alerts (above/below target), intraday percentage moves, RSI overbought/oversold levels, 50-day and 200-day moving average crossovers (golden cross / death cross), relative volume (RVOL) spikes, confirmed earnings date releases, and SEC Form-4 insider transaction filings.

Question 4

How quickly will I be notified about CGEM price changes?

Accepted Answer

CGEM alerts are evaluated continuously in real-time against live market telemetry. Notifications are dispatched within sub-second latency via push notifications, SMS, or phone calls as soon as your trigger condition is met across regular, pre-market, and after-hours trading sessions.

Question 5

Is Stock Alarm Pro free to use for CGEM alerts?

Accepted Answer

Yes, Stock Alarm Pro offers a free tier that includes 3 active price alerts for CGEM and other stocks. Full Pro membership is $20/month or $168/year with a 7-day free trial, unlocking unlimited alerts, phone call delivery, SMS, all 125+ technical indicators, institutional screeners, and real-time market telemetry across web, iOS, and Android.

Reported	EPS est	EPS actual	Surprise	Revenue est	Revenue actual	Surprise
Aug 6 2026	($0.80)	($0.81)	-1.3%	$4M	—	—
May 7 2026	($0.84)	($0.75)	+10.3%	$4M	—	—
Mar 10 2026	($0.80)	($0.77)	+3.8%	$5M	—	—
Nov 6 2025	($0.95)	($0.77)	+18.9%	$6M	—	—
Aug 7 2025	($0.83)	($1.07)	-28.9%	—	—	—
May 8 2025	($0.78)	($0.74)	+5.1%	—	—	—
Feb 27 2025	($0.75)	($0.73)	+2.7%	—	—	—
Nov 7 2024	($0.78)	($0.69)	+11.5%	—	—	—
Aug 8 2024	($0.73)	($0.75)	-2.7%	—	—	—
May 15 2024	($0.90)	($0.86)	+4.4%	—	—	—
Mar 14 2024	($0.96)	($0.54)	+43.7%	—	—	—
Nov 8 2023	($0.91)	($0.91)	+0.0%	—	—	—

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$13M	$58M	$53M	$89M	$257M
Low	$6M	$14M	$27M	$46M	$132M
High	$23M	$131M	$96M	$161M	$465M
EBITDA Avg	$-204M	$-170M	$-183M	$-174M	$-96M
Low	$-211M	$-184M	$-200M	$-358M	$-198M
High	$-166M	$-106M	$-167M	$-64M	$-35M
EBIT Avg	$-204M	$-171M	$-184M	$-174M	$-97M
Low	$-211M	$-184M	$-200M	$-358M	$-199M
High	$-166M	$-106M	$-167M	$-65M	$-36M
Net Income Avg	$-204M	$-171M	$-184M	$-174M	$-97M
Low	$-211M	$-184M	$-200M	$-358M	$-199M
High	$-166M	$-106M	$-167M	$-65M	$-36M
EPS Avg	$-3.17	$-2.50	$-3.05	$-2.96	$-1.64
Low	$-3.58	$-3.12	$-3.40	$-6.07	$-3.37
High	$-2.81	$-1.80	$-2.83	$-1.09	$-0.61
Analysts (Rev / EPS)	7 / 8	8 / 8	8 / 7	6 / 2	6 / 4

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$13M	$15M	$2M	$4M	$70M	—	—	—
Low	$13M	$15M	$2M	$4M	$70M	—	—	—
High	$13M	$15M	$2M	$4M	$70M	—	—	—
EBITDA Avg	$-44M	$-35M	$-51M	$-55M	$-27M	—	—	—
Low	$-55M	$-35M	$-51M	$-55M	$-27M	—	—	—
High	$-22M	$-35M	$-51M	$-55M	$-27M	—	—	—
EBIT Avg	$-44M	$-35M	$-52M	$-55M	$-27M	—	—	—
Low	$-55M	$-35M	$-52M	$-55M	$-27M	—	—	—
High	$-22M	$-35M	$-52M	$-55M	$-27M	—	—	—
Net Income Avg	$-44M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
Low	$-55M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
High	$-22M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
EPS Avg	$-0.71	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
Low	$-0.89	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
High	$-0.36	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
Analysts (Rev / EPS)	5 / 7	4 / 2	4 / 2	4 / 2	4 / 5	— / 6	— / 5	— / 4

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$13M	$58M	$53M	$89M	$257M
Low	$6M	$14M	$27M	$46M	$132M
High	$23M	$131M	$96M	$161M	$465M
EBITDA Avg	$-204M	$-170M	$-183M	$-174M	$-96M
Low	$-211M	$-184M	$-200M	$-358M	$-198M
High	$-166M	$-106M	$-167M	$-64M	$-35M
EBIT Avg	$-204M	$-171M	$-184M	$-174M	$-97M
Low	$-211M	$-184M	$-200M	$-358M	$-199M
High	$-166M	$-106M	$-167M	$-65M	$-36M
Net Income Avg	$-204M	$-171M	$-184M	$-174M	$-97M
Low	$-211M	$-184M	$-200M	$-358M	$-199M
High	$-166M	$-106M	$-167M	$-65M	$-36M
EPS Avg	$-3.17	$-2.50	$-3.05	$-2.96	$-1.64
Low	$-3.58	$-3.12	$-3.40	$-6.07	$-3.37
High	$-2.81	$-1.80	$-2.83	$-1.09	$-0.61
Analysts (Rev / EPS)	7 / 8	8 / 8	8 / 7	6 / 2	6 / 4

Metric	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028	Q3 2028
Revenue Avg	$13M	$15M	$2M	$4M	$70M	—	—	—
Low	$13M	$15M	$2M	$4M	$70M	—	—	—
High	$13M	$15M	$2M	$4M	$70M	—	—	—
EBITDA Avg	$-44M	$-35M	$-51M	$-55M	$-27M	—	—	—
Low	$-55M	$-35M	$-51M	$-55M	$-27M	—	—	—
High	$-22M	$-35M	$-51M	$-55M	$-27M	—	—	—
EBIT Avg	$-44M	$-35M	$-52M	$-55M	$-27M	—	—	—
Low	$-55M	$-35M	$-52M	$-55M	$-27M	—	—	—
High	$-22M	$-35M	$-52M	$-55M	$-27M	—	—	—
Net Income Avg	$-44M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
Low	$-55M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
High	$-22M	$-35M	$-52M	$-55M	$-27M	$20M	$-50M	$-52M
EPS Avg	$-0.71	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
Low	$-0.89	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
High	$-0.36	$-0.57	$-0.84	$-0.89	$-0.43	$0.32	$-0.82	$-0.84
Analysts (Rev / EPS)	5 / 7	4 / 2	4 / 2	4 / 2	4 / 5	— / 6	— / 5	— / 4

EPS surprise

Earnings & Revenue Estimates

Explore More